Release Date: 18/11/20 08:23 Summary: Canary Capital Appointed as Corporate Advisor Price Sensitive: No Download Document 135.86KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%